• Je něco špatně v tomto záznamu ?

HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis

L. Janeckova, V. Pospichalova, B. Fafilek, M. Vojtechova, J. Tureckova, J. Dobes, M. Dubuissez, D. Leprince, N. Baloghova, M. Horazna, A. Hlavata, J. Stancikova, E. Sloncova, K. Galuskova, H. Strnad, V. Korinek,

. 2015 ; 13 (7) : 1139-48. [pub] 20150501

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010242

UNLABELLED: Hypermethylated in cancer 1 (HIC1) represents a prototypic tumor suppressor gene frequently inactivated by DNA methylation in many types of solid tumors. The gene encodes a sequence-specific transcriptional repressor controlling expression of several genes involved in cell cycle or stress control. In this study, a Hic1 allele was conditionally deleted, using a Cre/loxP system, to identify genes influenced by the loss of Hic1. One of the transcripts upregulated upon Hic1 ablation is the toll-like receptor 2 (TLR2). Tlr2 expression levels increased in Hic1-deficient mouse embryonic fibroblasts (MEF) and cultured intestinal organoids or in human cells upon HIC1 knockdown. In addition, HIC1 associated with the TLR2 gene regulatory elements, as detected by chromatin immunoprecipitation, indicating that Tlr2 indeed represents a direct Hic1 target. The Tlr2 receptor senses "danger" signals of microbial or endogenous origin to trigger multiple signaling pathways, including NF-κB signaling. Interestingly, Hic1 deficiency promoted NF-κB pathway activity not only in cells stimulated with Tlr2 ligand, but also in cells treated with NF-κB activators that stimulate different surface receptors. In the intestine, Hic1 is mainly expressed in differentiated epithelial cells and its ablation leads to increased Tlr2 production. Finally, in a chemical-induced mouse model of carcinogenesis, Hic1 absence resulted in larger Tlr2-positive colonic tumors that showed increased proportion of proliferating cells. IMPLICATIONS: The tumor-suppressive function of Hic1 in colon is related to its inhibitory action on proproliferative signaling mediated by the Tlr2 receptor present on tumor cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010242
003      
CZ-PrNML
005      
20160415121125.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/1541-7786.MCR-15-0033 $2 doi
024    7_
$a 10.1158/1541-7786.MCR-15-0033 $2 doi
035    __
$a (PubMed)25934696
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Janeckova, Lucie $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
245    10
$a HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis / $c L. Janeckova, V. Pospichalova, B. Fafilek, M. Vojtechova, J. Tureckova, J. Dobes, M. Dubuissez, D. Leprince, N. Baloghova, M. Horazna, A. Hlavata, J. Stancikova, E. Sloncova, K. Galuskova, H. Strnad, V. Korinek,
520    9_
$a UNLABELLED: Hypermethylated in cancer 1 (HIC1) represents a prototypic tumor suppressor gene frequently inactivated by DNA methylation in many types of solid tumors. The gene encodes a sequence-specific transcriptional repressor controlling expression of several genes involved in cell cycle or stress control. In this study, a Hic1 allele was conditionally deleted, using a Cre/loxP system, to identify genes influenced by the loss of Hic1. One of the transcripts upregulated upon Hic1 ablation is the toll-like receptor 2 (TLR2). Tlr2 expression levels increased in Hic1-deficient mouse embryonic fibroblasts (MEF) and cultured intestinal organoids or in human cells upon HIC1 knockdown. In addition, HIC1 associated with the TLR2 gene regulatory elements, as detected by chromatin immunoprecipitation, indicating that Tlr2 indeed represents a direct Hic1 target. The Tlr2 receptor senses "danger" signals of microbial or endogenous origin to trigger multiple signaling pathways, including NF-κB signaling. Interestingly, Hic1 deficiency promoted NF-κB pathway activity not only in cells stimulated with Tlr2 ligand, but also in cells treated with NF-κB activators that stimulate different surface receptors. In the intestine, Hic1 is mainly expressed in differentiated epithelial cells and its ablation leads to increased Tlr2 production. Finally, in a chemical-induced mouse model of carcinogenesis, Hic1 absence resulted in larger Tlr2-positive colonic tumors that showed increased proportion of proliferating cells. IMPLICATIONS: The tumor-suppressive function of Hic1 in colon is related to its inhibitory action on proproliferative signaling mediated by the Tlr2 receptor present on tumor cells.
650    _2
$a zvířata $7 D000818
650    _2
$a azoxymethan $7 D001397
650    _2
$a karcinogeneze $x metabolismus $7 D063646
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $7 D049109
650    _2
$a nádory tračníku $7 D003110
650    _2
$a síran dextranu $7 D016264
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a epitelové buňky $7 D004847
650    _2
$a genový knockdown $7 D055785
650    _2
$a lidé $7 D006801
650    _2
$a střeva $x cytologie $7 D007422
650    _2
$a transkripční faktory Krüppel-like $x genetika $x metabolismus $7 D051741
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    12
$a signální transdukce $7 D015398
650    _2
$a toll-like receptor 2 $x metabolismus $7 D051195
650    _2
$a nádorové supresorové proteiny $x metabolismus $7 D025521
650    _2
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pospichalova, Vendula $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Fafilek, Bohumil $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Vojtechova, Martina $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Tureckova, Jolana $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Dobes, Jan $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Dubuissez, Marion $u CNRS UMR 8161, Institut de Biologie de Lille, Université Lille Nord de France, Institut Pasteur de Lille, Lille Cedex, France.
700    1_
$a Leprince, Dominique $u CNRS UMR 8161, Institut de Biologie de Lille, Université Lille Nord de France, Institut Pasteur de Lille, Lille Cedex, France.
700    1_
$a Baloghova, Nikol $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Horazna, Monika $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Hlavata, Adela $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Stancikova, Jitka $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Sloncova, Eva $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Galuskova, Katerina $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Strnad, Hynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Korinek, Vladimir $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic. korinek@img.cas.cz.
773    0_
$w MED00007101 $t Molecular cancer research MCR $x 1557-3125 $g Roč. 13, č. 7 (2015), s. 1139-48
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25934696 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160415121210 $b ABA008
999    __
$a ok $b bmc $g 1113671 $s 934610
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 13 $c 7 $d 1139-48 $e 20150501 $i 1557-3125 $m Molecular cancer research $n Mol Cancer Res $x MED00007101
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...